FI
DGX icon

FormulaFolio Investments’s Quest Diagnostics DGX Stock Holding History

FormulaFolio Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$12K Hold
89
– – ﹤0.01% 233
2021
Q1 		$12K Buy
+89
New +$11K ﹤0.01% 231
2016
Q2 		– Sell
-12,954
Closed -$926K – 127
2016
Q1 		$926K Buy
+12,954
New +$869K 0.16% 54

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

FormulaFolio Investments's DGX Position: Q2 2021 in Review

FormulaFolio Investments held its Quest Diagnostics (DGX) position steady in Q2 2021 at 89 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #233.

FormulaFolio Investments first reported a position in DGX in Q1 2016 and has held it in 3 quarters since. The position peaked at $926K in Q1 2016. 814 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

  • FormulaFolio Investments held 89 shares of Quest Diagnostics worth $12K as of Q2 2021.
  • FormulaFolio Investments left its Quest Diagnostics share count unchanged in Q2 2021.
  • Quest Diagnostics made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #233 holding.
  • FormulaFolio Investments first reported a position in Quest Diagnostics in Q1 2016 and has held it in 3 quarters since.
  • FormulaFolio Investments's Quest Diagnostics position peaked at $926K in Q1 2016.
  • 814 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.